Crossbow Therapeutics
Cambridge, United States · Founded 2023 · $77.0M raised
- Headquarters
- Cambridge, Massachusetts
- Founded
- 2023
- Business Model
- B2B
- Website
- crossbowtherapeutics.com
- Total Funding
- $77.0M
- Last Round
- $77.0M Series BMar 2026
- Rounds
- 1
About
Biotech developing T-cell engager bispecific antibodies (T-Bolts) for cancer immunotherapy; Phase 1 trial ongoing.
Summary
Crossbow Therapeutics is a Biotech company based in Cambridge, United States, founded in 2023. It has raised $77.0M in total across 1 round, most recently a $77.0M Series B round in Mar 2026.
Sign up to view the funding chart
Create a free account — 25 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Mar 2026
Similar Companies
China's leading blood products manufacturer
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company